208 related articles for article (PubMed ID: 25666873)
1. Cancer stem cell targeting: are we there yet?
Jung Y; Kim WY
Arch Pharm Res; 2015 Mar; 38(3):414-22. PubMed ID: 25666873
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cells: a challenging paradigm for designing targeted drug therapies.
Khan IN; Al-Karim S; Bora RS; Chaudhary AG; Saini KS
Drug Discov Today; 2015 Oct; 20(10):1205-16. PubMed ID: 26143148
[TBL] [Abstract][Full Text] [Related]
3. Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine.
Winquist RJ; Boucher DM; Wood M; Furey BF
Biochem Pharmacol; 2009 Aug; 78(4):326-34. PubMed ID: 19539800
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cells--important players in tumor therapy resistance.
Colak S; Medema JP
FEBS J; 2014 Nov; 281(21):4779-91. PubMed ID: 25158828
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
6. Implications of cancer stem cells in the treatment of cancer.
Pan CX; Zhu W; Cheng L
Future Oncol; 2006 Dec; 2(6):723-31. PubMed ID: 17155899
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem cells: the development of new cancer therapeutics.
Scatena R; Bottoni P; Pontoglio A; Giardina B
Expert Opin Biol Ther; 2011 Jul; 11(7):875-92. PubMed ID: 21463158
[TBL] [Abstract][Full Text] [Related]
8. [Clinical research of targeting therapy for cancer stem cells].
Shitara K; Doi T
Nihon Rinsho; 2015 May; 73(5):823-30. PubMed ID: 25985638
[TBL] [Abstract][Full Text] [Related]
9. Multimodal Nanomedicine Strategies for Targeting Cancer Cells as well as Cancer Stem Cell Signalling Mechanisms.
Kanwar JR; Samarasinghe RM; Kamalapuram SK; Kanwar RK
Mini Rev Med Chem; 2017; 17(18):1688-1695. PubMed ID: 26891936
[TBL] [Abstract][Full Text] [Related]
10. Approaches for targeting cancer stem cells drug resistance.
Rosa R; D'Amato V; De Placido S; Bianco R
Expert Opin Drug Discov; 2016 Dec; 11(12):1201-1212. PubMed ID: 27700193
[TBL] [Abstract][Full Text] [Related]
11. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
Garg M
Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
[TBL] [Abstract][Full Text] [Related]
12. The bad seed gardener: Deubiquitinases in the cancer stem-cell signaling network and therapeutic resistance.
Qiu GZ; Sun W; Jin MZ; Lin J; Lu PG; Jin WL
Pharmacol Ther; 2017 Apr; 172():127-138. PubMed ID: 27919796
[TBL] [Abstract][Full Text] [Related]
13. Molecular Pathways: Targeting Cancer Stem Cells Awakened by Chemotherapy to Abrogate Tumor Repopulation.
Chan KS
Clin Cancer Res; 2016 Feb; 22(4):802-6. PubMed ID: 26671994
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cell targeted therapy: progress amid controversies.
Wang T; Shigdar S; Gantier MP; Hou Y; Wang L; Li Y; Shamaileh HA; Yin W; Zhou SF; Zhao X; Duan W
Oncotarget; 2015 Dec; 6(42):44191-206. PubMed ID: 26496035
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells: an approach to identify newer therapeutic targets.
Srivastava S; Krishna S
J Stem Cells; 2009; 4(2):123-31. PubMed ID: 20232597
[TBL] [Abstract][Full Text] [Related]
16. [Pancreatic cancer stem cell].
Hamada S; Masamune A; Shimosegawa T
Nihon Rinsho; 2015 May; 73(5):844-9. PubMed ID: 25985641
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells as a target population for drug discovery.
Bouvard C; Barefield C; Zhu S
Future Med Chem; 2014 Sep; 6(14):1567-85. PubMed ID: 25367391
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem cells: biological functions and therapeutically targeting.
Ciurea ME; Georgescu AM; Purcaru SO; Artene SA; Emami GH; Boldeanu MV; Tache DE; Dricu A
Int J Mol Sci; 2014 May; 15(5):8169-85. PubMed ID: 24821540
[TBL] [Abstract][Full Text] [Related]
19. Rational targeting of Notch signaling in cancer.
Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
[TBL] [Abstract][Full Text] [Related]
20. Minimal residual disease in cancer therapy--Small things make all the difference.
Blatter S; Rottenberg S
Drug Resist Updat; 2015; 21-22():1-10. PubMed ID: 26307504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
